Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-α and interleukin-6 in patients with sepsis

被引:114
作者
Oberhoffer, M
Karzai, W
Meier-Hellmann, A
Bögel, D
Fassbinder, J
Reinhart, K [1 ]
机构
[1] Univ Jena, Dept Anesthesiol & Intens Care Med, D-07740 Jena, Germany
[2] Univ Jena, Inst Med Stat Informat & Documentat, D-07740 Jena, Germany
关键词
body temperature; leukocyte count; C-reactive protein; procalcitonin; tumor necrosis factor-alpha; interleukin-6; correlation; receiver operating characteristic; predictive value;
D O I
10.1097/00003246-199909000-00018
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To determine correlations and predictive strength of surrogate markers (body temperature, leukocyte count, C-reactive protein [CRP], and procalcitonin [PCT]) with elevated levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in septic patients. Design: Prospective consecutive case series. Setting: Surgical intensive care unit (ICU) of a university hospital, Patients: A total of 175 patients experiencing intensive care unit stays >48 hrs categorized for sepsis according to ACCP/SCCM Consensus Conference criteria. Measurements and Main Results: CRP and PCT were both significantly correlated with TNF-alpha and IL-6, Based on the area-under-the-curve of the receiver operating characteristics curves, predicting capability was highest for PCT (0.814 for TNF-alpha >40 pg/mL and 0.794 for IL-6 >500 pg/mL), moderate with CRP (0.732 and 0.716, respectively), and lowest for leukocyte count (0.493 and 0.483, respectively) and body temperature (0.587 and 0.589, respectively). Sensitivity, specificity, positive, and negative predictive values and test effectiveness all followed this same pattern of being highest for PCT followed by CRP, with leukocyte count and body temperature being lowest. Conclusion: PCT may be an early and better marker of elevated cytokines than the more classic criteria of inflammation.
引用
收藏
页码:1814 / 1818
页数:5
相关论文
共 28 条
  • [1] Agresti A., 1990, Analysis of categorical data
  • [2] HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION
    ASSICOT, M
    GENDREL, D
    CARSIN, H
    RAYMOND, J
    GUILBAUD, J
    BOHUON, C
    [J]. LANCET, 1993, 341 (8844) : 515 - 518
  • [3] AN OVERVIEW OF MORTALITY RISK PREDICTION IN SEPSIS
    BARRIERE, SL
    LOWRY, SF
    [J]. CRITICAL CARE MEDICINE, 1995, 23 (02) : 376 - 393
  • [4] Why sepsis trials fail
    Bone, RC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (07): : 565 - 566
  • [5] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [6] BRETAGNA XY, 1978, J CLIN ENDOCR METAB, V47, P1390
  • [7] Kinetics of procalcitonin in iatrogenic sepsis
    Brunkhorst, FM
    Heinz, U
    Forycki, ZF
    [J]. INTENSIVE CARE MEDICINE, 1998, 24 (08) : 888 - 889
  • [8] Brunkhorst FM, 1995, INTENS CARE MED, V21, P12
  • [9] BUHOUN C, 1994, CLIN INTENSIVE CARE, V5, P88
  • [10] PLASMA CYTOKINE AND ENDOTOXIN LEVELS CORRELATE WITH SURVIVAL IN PATIENTS WITH THE SEPSIS SYNDROME
    CASEY, LC
    BALK, RA
    BONE, RC
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) : 771 - 778